Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-27
2000-06-27
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514538, 514563, 514617, 544353, 544365, 546111, 546121, 546169, 546194, 546278, 546280, 546281, 546284, 546332, 548128, 548204, 548255, 5483094, 5483361, 5483741, 549366, 549441, 560 35, 560251, 562440, 564157, 564161, C07C25718, A61K 31216
Patent
active
060807679
ABSTRACT:
The compounds according to the invention are substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides of formula I herein which exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More especially, they are Factor Xa inhibitors. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, methods for their preparation and their use, which are for treating a patient suffering from, or subject to, conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
REFERENCES:
patent: 5424334 (1995-06-01), Abood
Guertin Kevin R.
Klein Scott I.
Spada Alfred P.
Aventis Pharmaceuticals Products Inc.
Gerstl Robert
Oehler Ross J.
LandOfFree
Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl am does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl am, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl am will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785090